Instead, upregulation of activating molecules like NKG2D on NK cells [77] or the use of allogeneic and autologous cytokine-activated (IL-2 or IL-15) NK cells are important to prime NK cells to eliminate glioblastoma cells and overcome the failure of immune surveillance. This evidence concerns the gene KLRK1 and glioblastoma.